Antithrombotic Trialists'(ATT)Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials [J]. Lancet, 2009, 373(9678):1849-1860.
[2]
Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity [J]. Eur Heart J,2006,27(6): 647-654.
Fitzgerald R, Pirmohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors[J]. Pharmacol Ther,2011,130(2):213-225.
[5]
Patrono C, Rocca B. Aspirin: promise and resistance in the new millennium [J]. Arterioscler Thromb Vasc Biol,2008, 28(3): s25-s32.
[6]
Schwartz KA, Schwartz DE, Barber K, et al. Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients[J]. J Transl Med, 2008,6:46.
[7]
Kasotakis G, Pipinos II, Lynch TG. Current evidence and clinical implications of aspirin resistance [J]. J Vasc Surg,2009, 50(6): 1500-1510.
[8]
Cuisset T, Frere C, Quilici J, et al. Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting[J]. Am Heart J,2009, 157(5):889-893.
[9]
Spektor G, Fuster V. Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk-where are we now? [J]. Nat Clin Pract Cardiovasc Med,2005,2(6):290-300.
[10]
Kour D, Tandon VR, Kapoor B, et al. Aspirin Resistance [J]. JK Science,2006,8(2):116-117.
[11]
Bauriedel G, Skowasch D, Schneider M, et al. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry[J]. Am Heart J,2003, 145(2):343-348.
[12]
Reavey-Cantwell JF, Fox WC, Reichwage BD, et al. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery [J]. Neurosurgery, 2009,64(5):890-895.
[13]
Kovanen PT, Pentikainen MO. Pharmacologic prevention of coronary plaque rupture-the major cause of acute coronary syndromes [J]. Heart Metab,2007,36:9-14.
[14]
Kunicki TJ, Williams SA, Nugent DJ, et al. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease[J]. Thromb Haemost,2009,101(1):123-133.
